Skip to main content

Table 2 Sepsis source and bundle management of cirrhotic patients with septic shock (n = 88)

From: Effectiveness of sepsis bundle application and outcomes predictors to cirrhotic patients with septic shock

Variables

All (n = 88)

Non-survivors (n = 47)

Survivors (n = 41)

p value

Bacteremia, n (%)

52 (59.1)

27 (57.4)

25 (61.0)

0.83

Infection Source, n (%)

 Respiratory tract infection

16 (18.2)

13 (27.7)

3 (7.3)

0.03*

 Urinary tract infection

13 (14.8)

5 (10.6)

8 (19.5)

0.37

 Spontaneous bacterial peritonitis

30 (34.1)

19 (40.4)

11 (26.8)

0.26

 Biliary tract infection

9 (10.2)

1 (2.1)

8 (19.5)

0.01*

 Soft tissue infection

12 (13.6)

4 (8.5)

8 (19.5)

0.21

 Other

8 (9.1)

5 (10.6)

3 (7.3)

0.72

Appropriate antibiotics, n (%)

65 (73.9)

35 (74.5)

30 (73.2)

1.00

Source control, n (%)

11 (12.5)

2 (4.3)

9 (22.0)

0.02*

1st dose antibiotics administration time, minutes, median (IQR)

85.0 (44.8–149.5)

94.0 (47.0–150)

70.0 (29.5–165)

0.31

Vasopressor initiation time, minutes, median (IQR)

103.0 (68–151.3)

115.0 (70–175)

80.0 (51–133.5)

0.37

Fluid amount, L, median (IQR)

1.2 (0.7–1.6)

1.0 (0.5–1.5)

1.3 (1.0–1.6)

0.16

Hour-1 bundle achievement, n (%)

27 (30.7)

12 (25.5)

15 (36.6)

0.35

  1. *P < 0.05